Exercise and Beetroot Juice for Peripheral Arterial Disease
(IMPACT PAD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether home-based exercise and nitrate-rich beetroot juice can help individuals with Peripheral Arterial Disease (PAD) improve their walking ability. Researchers aim to determine if these treatments are more effective than surgery alone in enhancing blood flow in the legs. Individuals who have undergone a successful procedure to improve leg blood flow and experience walking difficulties due to PAD may be suitable candidates. Participants should not frequently consume beetroot or be on certain medications and must be willing to try exercise and beetroot juice as part of the study. As a Phase 3 trial, this study represents the final step before FDA approval, offering participants the opportunity to contribute to potentially groundbreaking treatment advancements.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking sildenafil, tadalafil, or related drugs. Additionally, you must stop consuming beetroot juice, oral nitrate or nitrite, or beetroot supplements for 30 days before the trial and throughout the study.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that exercising at home is generally safe for people with Peripheral Arterial Disease (PAD). Studies have found that it can significantly improve walking distance and speed. Many people find this type of exercise manageable and notice they can walk longer distances.
Regarding nitrate-rich beetroot juice, research suggests it is also safe and well-tolerated for those with PAD. It may help improve blood flow and overall exercise capacity. These findings are encouraging, indicating that both treatments have been tested for safety and have shown positive results in past studies.12345Why are researchers excited about this trial's treatments?
Researchers are excited about these treatments for Peripheral Arterial Disease (PAD) because they offer a natural approach that could complement or enhance existing therapies like medications and supervised exercise programs. The use of nitrate-rich beetroot juice is particularly intriguing because it may improve blood flow by increasing nitric oxide levels, which can enhance vascular function and reduce symptoms of PAD. Additionally, combining home-based exercise with beetroot juice provides a potentially accessible and convenient treatment option for patients who may have difficulty accessing traditional in-clinic exercise programs. By exploring these innovative strategies, researchers hope to discover more effective and easily implementable ways to manage PAD symptoms.
What evidence suggests that this trial's treatments could be effective for improving walking performance in PAD patients?
Research has shown that drinking beetroot juice, which is high in nitrates, might help people with Peripheral Arterial Disease (PAD) walk better. Studies have found that it increases nitric oxide, improving blood flow and making exercise easier. This improvement may allow for longer walks with less pain. Beetroot juice has also been shown to lower blood pressure, which aids in managing PAD. In this trial, one group will engage in home-based exercise while drinking nitrate-rich beetroot juice, potentially enhancing these benefits and enabling more effective training with less discomfort. Another group will receive attention control with nitrate-rich beetroot juice. Additionally, some participants will receive placebo beetroot juice without nitrate, either with home-based exercise or attention control. Overall, promising evidence suggests that beetroot juice and exercise together can improve walking in people with PAD.678910
Are You a Good Fit for This Trial?
This trial is for patients with Peripheral Artery Disease (PAD) who have undergone revascularization but still experience walking difficulties. Participants should be within three months post-successful revascularization and willing to follow a home-based exercise program or consume beetroot juice.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in home-based exercise and consume nitrate-rich beetroot juice or placebo for six months
Follow-up
Participants are monitored for changes in six-minute walk distance and other mobility measures
Extended Follow-up
Participants are monitored for long-term outcomes such as prevention of hemodynamic failure and mobility improvements
What Are the Treatments Tested in This Trial?
Interventions
- Home Based Exercise
- Nitrate Rich Beetroot Juice
- Placebo Beetroot Juice Without Nitrate
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
Rancho Research Institute
Collaborator
University of Chicago
Collaborator
Wake Forest University
Collaborator
University of Pittsburgh Medical Center
Collaborator
Emory University
Collaborator
University of Arizona
Collaborator
Dartmouth-Hitchcock Medical Center
Collaborator